Related Articles

• Nedaplatin and irinotecan combination therapy is equally effective and less toxic than cisplatin and irinotecan for patients with primary clear cell adenocarcinoma of the ovary and recurrent ovarian carcinoma
• Survival analysis of ovarian clear cell carcinoma confined to the ovary with or without comprehensive surgical staging
• Exploratory study of effective chemotherapy to clear cell carcinoma of the ovary.
• Role of endometriosis as a prognostic factor for post‑progression survival in ovarian clear cell carcinoma
• Prognosis of ovarian clear cell cancer compared with other epithelial cancer types: A population‑based analysis